Hematopoietins

AntiRat Erythrocytes(Clone OX-83,Mse IgG1 )100ug

AntiRat Erythrocytes(Clone OX-83,Mse IgG1 )100ug

AntiRat Erythrocytes(Clone OX-83,Mse IgG1 )250ug

Stabilizes HIF from degradation in the proteasome and increases endogenous production of erythropoietin by inhibiting HIF-1&alpha prolyl hydroxylase (IC₅₀ = 0.49 &microM) investigated in clinical trial for treatment of patients with

Stabilizes HIF from degradation in the proteasome and increases endogenous production of erythropoietin by inhibiting HIF-1&alpha prolyl hydroxylase (IC₅₀ = 0.49 &microM) investigated in clinical trial for treatment of patients with

Stabilizes HIF from degradation in the proteasome and increases endogenous production of erythropoietin by inhibiting HIF-1&alpha prolyl hydroxylase (IC₅₀ = 0.49 &microM) investigated in clinical trial for treatment of patients with

Stabilizes HIF from degradation in the proteasome and increases endogenous production of erythropoietin by inhibiting HIF-1&alpha prolyl hydroxylase (IC₅₀ = 0.49 &microM) investigated in clinical trial for treatment of patients with

The Brownlee SPP phenyl-hexyl guard cartridges are available to match the column phase. They require a holder, P/N N9308534.

The Brownlee SPP Phenyl-Hexyl guard cartridges are available to match the column phase. They require a holder, P/N N9308534.

Butyzamide is an orally active activator of Mpl , a thrombopoietin (TPO) receptor. Butyzamide increases the phosphorylation level of JAK2 , STAT3 , STAT5 and MAPK. Butyzamide increases the level of human platelets in mouse xenotransplantation

Butyzamide is an orally active activator of Mpl , a thrombopoietin (TPO) receptor. Butyzamide increases the phosphorylation level of JAK2 , STAT3 , STAT5 and MAPK. Butyzamide increases the level of human platelets in mouse xenotransplantation

Application:Flow: ≤1.0 μg/test:For flow cytometric staining, the suggested use of this reagent is ≤1.0 μg per million cells in 100 µL staining volume or 100 µL of whole blood.